MarketCap
Facebook
X
TelegramQuartalsbericht 2023-Q1
hinzugefügt 10.05.2023
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
104 M |
Marktkapitalisierung |
$ 4.46 B |
EBITDA (LTM) |
$ 391 M |
P/E (LTM) |
- |
P/S (LTM) |
0.84 |
EPS (LTM) |
0.91 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 119.77 | -0.5 % | $ 36.4 B | NYSE,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 20.56 | 3.37 % | $ 221 M | Nasdaq Global Market |  China |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 17.57 | -0.34 % | $ 936 M | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Co-Diagnostics
CODX
|
$ 1.42 | 2.9 % | $ 1.89 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 24.62 | 1.03 % | $ 684 M | Nasdaq Global Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 180.56 | 0.7 % | $ 8.95 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Danaher Corporation
DHR
|
$ 198.14 | -0.2 % | $ 141 B | NYSE,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 2.2 | - | $ 9.73 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 132.26 | 1.49 % | $ 21 B | Nasdaq Global Select Market,SPB | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 29.09 | - | $ 20 B | NYSE |  Niderland |
 |
Fulgent Genetics
FLGT
|
$ 16.17 | 0.94 % | $ 489 M | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 84.86 | -1.78 % | $ 10.6 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Anixa Biosciences
ANIX
|
$ 2.93 | 1.74 % | $ 95.1 K | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.11 | 0.48 % | $ 4.85 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 518.54 | -0.28 % | $ 15 B | Nasdaq Global Select Market,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 116.5 | 3.04 % | $ 9.61 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 266.73 | -0.8 % | $ 22.2 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Celcuity
CELC
|
$ 123.47 | 2.17 % | $ 5.77 B | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 5.19 | 5.7 % | $ 481 M | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 83.94 | 1.45 % | $ 5.67 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.68 | 3.95 % | $ 1.11 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.42 | -1.98 % | $ 2.04 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 191.42 | -1.41 % | $ 21.2 B | NYSE,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.14 | 3.63 % | $ 4.05 M | Nasdaq Global Select Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.84 | 4.69 % | $ 399 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 207.19 | -3.47 % | $ 20.4 B | Nasdaq Global Select Market,SPB | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |